Sharescart Research Club logo ×
Screener Research Buy Unlisted Shares Sell Unlisted Shares Startup Funding New IPO New

Mumbai, India

I'm Nimish, Co-founder of Beat The Street. We're the ultimate financial platform with 65k investors, focusing on financial market awareness through research and analysis. Our mission is to promote financial literacy and informed investing.

Read More..
Contributor since: 2023

22

Articles

20

Likes

4

Followers

Comments: 0 | Likes: 1 | Current Price: ₹ 2482


BSE's Derivative Business Analysis and Way Ahead

BSE's Derivative Business Analysis and Way Ahead


India's 2nd largest has been on roller coaster ride on the back of the relaunch of equity derivative business in May-2023.

Let's do some business analysis of BSE's Hot Business Segment and Way Ahead

1. Market Share - BSE has achieved notable success with its SENSEX contract, even in the considerably larger equity derivatives sector largely controlled by NSE. Presently, the SENSEX contract caters to roughly 40% of NSE's derivatives volume linked to NIFTY. However, the introduction of the BANKEX contract by BSE is expected to extend its influence over approximately 95% of NSE's derivative volume. This significant development has granted the exchange a remarkable market share of approximately 9/3% in terms of notional and premium.

2. Option Pricing - The current option pricing at BSE is merely a fraction of what NSE offers, a situation that is unlikely to be sustainable. It's anticipated that a pricing adjustment will take place soon, and we've already seen a threefold increase in options pricing. Yet, it still remains at a discount of about 57% compared to NSE's pricing. Currently, BSE charges approximately 1 basis point (bps) on options premium, while NSE charges around 7 bps. Under the new management, pricing discounts are being phased out in most segments, except for derivatives. Clearing options costs around 1 bps for both exchanges. It's important to note that BSE is not generating profits in the derivatives segment, which makes a pricing adjustment inevitable. However, the extent of this adjustment may vary. Considering past pricing actions, it's probable that the pricing will align more closely with NSE's rates in the future.

3. The Big Change - BSE implemented incremental derivative turnover charges with effect from 1st November 2023. This is the main reason why BSE stock surged 12% on 22nd Oct-23. 


4. Overall
similar to Derivative, BSE's cash market share is very small and yet to pick up



5. Key Growth Drivers for BSE going ahead

6.  The various sources of Revenue for BSE


7. BSE is itself a conglomerate of financial services




Last but the least - BSE's increased charges in derivative business need to be monitored along with retaining and increasing market share in the derivative business. Further launch of other equity derivative products is the key metric to be watched out

Disclosure:

I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Business relationship disclosure:

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Stocx Research Club). I have no business relationship with any company whose stock is mentioned in this article.

Disclosure legality:

I am not a SEBI Registered individual/entity and the above research article is only for educational purpose and is never intended as trading/investment advice.

Articles

Updated : Aug, 2025

What is Capital Gain on Unlisted Shares

Unlisted shares are taxed differently than listed shares, the tax treatment depends on the time we held the shares.If the shares are sold in 24 months the profit will be treated as Short Term Capital Gain (STCG) and taxed at the slab that matches your ...

Author : Sanidhya Ratnawat

Updated : Aug, 2025

Understanding the Impact of Economic Cycles on Unlis...

In the world of investing the big stage belongs to the stock exchanges like NSE and BSE where companies perform under the spotlight everyday. But behind the scenes away from the flashy lights and hypes there is something which is quieter and more excl...

Author : Sanidhya Ratnawat

Updated : Aug, 2025

How the Secondary Market Works for Buying and Sellin...

Everyone knows about the stock market, the magical place where companies like Reliance, Infosys and HDFC get traded on a daily basis on big name exchanges like NSE and BSE but what if I told you there’s an entire parallel market that doesn’t make m...

Author : Sanidhya Ratnawat

Updated : May, 2025

Top 10 Undervalued EV Stocks to Watch in 2025 for G...

India EV market is set for rapid growth in 2025, driven by strong government support, rising demand, and a maturing ecosystem. This article highlights 10 undervalued EV stocks—from OEMs (Original Equipment Manufacturer) to battery makers—that offer...

Author : Harsh Rajuka

Updated : Mar, 2025

Zomato Fairly Valued or a Bubble Waiting to Burst

Zomato !! Everyone's favourite food delivery app... or is it just a really good story we're all buying into? With a PE ratio that's sky-high and whispers of being a one-rupee stock, are we retail investors about to get served a dish of overhyped disapp...

Author : Ramya Naidu

Updated : Feb, 2025

Difference between Stock Market and Share Market

There’s two jargons in the investing world which are used interchangeably, which people think have the same meaning. However, above the clouds of myths, afloat the reality. Having the right set of knowledge is crucial when one steps out for investing...

Author : Harsh Rajuka

Updated : Oct, 2023

BSE's Derivative Business Analysis and Way Ahead

BSE's Derivative Business Analysis and Way Ahead

Author : Nimish Maheshwari

Updated : Jun, 2022

Equity Research Report: Sakar Healthcare

Sakar Healthcare Ltd is engaged in manufacturing of pharmaceutical formulations in the form of liquid injectables, tablets/ capsules, oral liquid syrups, dry powder injectables and syrups. Presently, its domestic sales accounts for 31% of revenues and ...

Author : Akshita

Updated : Jun, 2022

EQUITY RESEARCH REPORT: NEWGEN SOFTWARE

Newgen Software Technologies is a global software Company and is engaged in the business of software product development including designing and delivering end-to-end software solutions covering the entire spectrum of software services from workflow au...

Author : Akshita

Updated : Jun, 2022

Equity Research Report: Shree Renuka Sugar

Shree Renuka Sugars is a global agribusiness and bio-energy corporation. The Company is one of the largest sugar producers in the world, the leading manufacturer of sugar in India, and one of the largest sugar refineries in the world.

Author : Akshita

Updated : Jul, 2022

Equity Research : Tata Consumer Products Limited

TCPL future ambitions remain aggressive, At 17% EPS CAGR over FY22-25e, TCPL should deliver industry-leading growth within indian FMCG.

Author : Shalom Martin

Updated : Jul, 2022

Equity Research: Birlasoft Ltd

Birlasoft, a small-cap IT company, has an upside potential of 35%. The company’s repeated demonstration of ‘walking the talk’ makes us believe that it is on track to achieve its stated target of USD1bn revenue by FY25E.

Author : Shalom Martin

Updated : Jun, 2022

Nifty and Bank Nifty Tumbles Due to Weak Global Cues...

Nifty and Bank Nifty tumbles due to weak global cues lead by higher inflation data, higher crude oil prices and weakening currency.

Author : Shalom Martin

Comments

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....